Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Goblet cell and mucin gene abnormalities in asthma.

John V Fahy1

  • 1Division of Pulmonary and Critical Care Medicine, and the Cardiovascular Research Institute, University of California at San Francisco, San Francisco, CA 94143, USA. jfahy@itsa.ucsf.edu

Chest
|December 12, 2002
PubMed
Summary

Goblet cell hyperplasia (GCH) in asthma involves increased mucin (MUC) production, contributing to airway issues. Understanding GCH mechanisms may reveal new therapeutic targets for mucus hypersecretion.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lower plasma resolvin D1 level and greater sputum eosinophilia characterize a cluster of severe asthma patients.

Respiratory research·2026
Same author

Airway Mucus Plugs in Asthma and COPD: Pathobiology, Imaging, and Implications for Clinical Trials.

American journal of respiratory and critical care medicine·2026
Same author

Mucus plugs in chronic obstructive pulmonary disease are heterogeneous in size and shape and occur in relatively large airways.

American journal of respiratory and critical care medicine·2026
Same author

The pathobiology and treatment of mucus plugs in asthma and COPD: state of the art.

The European respiratory journal·2026
Same author

PrecISE-a biomarker-stratified adaptive trial of 5 interventions in severe asthma: Final protocol and the baseline cohort.

The Journal of allergy and clinical immunology·2026
Same author

High airway thymic stromal lymphopoietin in asthma is associated with type 2 inflammation, mucus plugging, and airway remodeling.

The Journal of allergy and clinical immunology·2025

Area of Science:

  • Pulmonary Medicine
  • Cell Biology
  • Immunology

Background:

  • Goblet cell hyperplasia (GCH) is a key feature across all asthma severities.
  • Altered mucin (MUC) storage and secretion are linked to GCH, impacting asthma symptoms.
  • Mucus hypersecretion is a significant cause of asthma-related morbidity and mortality.

Purpose of the Study:

  • To explore the molecular mechanisms underlying cytokine-induced GCH in asthma.
  • To investigate the relationship between MUC gene expression and GCH.
  • To identify potential therapeutic targets for treating mucus hypersecretion in asthma.

Main Methods:

  • Review of existing literature on GCH, MUC production, and T-helper type-2 cytokines in asthma.
  • Analysis of the role of CD4(+) T cells and associated cytokines in mediating GCH.

Related Experiment Videos

  • Exploration of the involvement of ion channels in GCH and goblet cell degranulation.

    • Main Results:

    • CD4(+) T cells and T-helper type-2 cytokines are critical mediators of GCH.
    • MUC5AC is the primary mucin gene expressed in asthma-related GCH.
    • Ongoing research focuses on cytokine-induced GCH, MUC gene regulation, and ion channel function.

    Conclusions:

    • Understanding the molecular pathways of GCH and goblet cell degranulation is crucial for developing new asthma therapies.
    • Targeting GCH and mucus hypersecretion offers a promising avenue for improving asthma treatment.
    • Novel therapeutic interventions are urgently needed due to the significant impact of mucus hypersecretion on asthma patients.